Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Piper Sandler Analyst Raises Price Target for First Financial Northwest Expresses Bullish Sentiment

Elaine Mendonca by Elaine Mendonca
January 12, 2024
in Breaking News
0
Finance_ stocks to buy
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On January 12, 2024, Piper Sandler analyst Andrew Liesch expressed his bullish sentiment towards First Financial Northwest (NASDAQ:FFNW) by maintaining an Overweight rating and significantly raising the price target from $14 to $23.50. This optimistic stance indicates a favorable outlook for the company’s stock and hints at an anticipated rise in its overall worth. Liesch’s increased price target signifies his unwavering confidence in the company’s ability to deliver impressive performance and exhibit substantial growth potential.

FFNW Stock Shows Strong Performance with Positive Momentum and Investor Confidence

On January 12, 2024, First Financial Northwest, Inc. (FFNW) exhibited a strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, FFNW demonstrated positive momentum and investor confidence.

The price of FFNW shares experienced a notable increase of $0.39 since the market closed, representing a rise of 1.95%. Closing at $20.64, FFNW showcased its upward trajectory and potential for growth.

Despite the market closing, FFNW’s stock remained unchanged in after-hours trading. This stability further reinforces the positive sentiment surrounding the company and its stock.

The fact that FFNW is trading near the top of its 52-week range indicates that investors have recognized its value and are willing to pay a premium for its shares. This suggests that FFNW has been performing well and has gained significant attention from market participants.

Moreover, the stock’s ability to stay above its 200-day simple moving average is a positive sign for investors. The 200-day moving average is a widely followed technical indicator that helps identify the overall trend of a stock. In this case, FFNW’s ability to remain above this moving average indicates a sustained upward trend, which is a bullish signal for investors.

The 1.95% rise in FFNW’s stock price on January 12 further highlights the positive sentiment surrounding the company. This increase demonstrates that investors are optimistic about FFNW’s future prospects and are willing to buy shares at a higher price.

Closing at $20.64, FFNW’s stock price indicates that the company is performing well and has the potential for further growth. Investors who purchased FFNW shares at a lower price may have already realized a profit, while those considering investing in the company may be enticed by its recent positive performance.

Although the stock remained unchanged in after-hours trading, this stability is not necessarily a negative sign. It suggests that investors have confidence in FFNW’s current price and are not rushing to sell their shares. This stability can be seen as a vote of confidence in the company’s long-term prospects.

In conclusion, FFNW exhibited strong performance on January 12, 2024. Trading near the top of its 52-week range and above its 200-day simple moving average, FFNW showcased positive momentum and investor confidence. The $0.39 increase in its stock price, representing a rise of 1.95%, further highlights the company’s upward trajectory. Closing at $20.64, FFNW’s stock price indicates a promising outlook for the company. Investors who recognize its potential may find FFNW to be an attractive investment opportunity.

First Financial Northwest, Inc. (FFNW) Stock Performance Remains Stable with Positive Growth in Revenue, Net Income, and EPS

On January 12, 2024, the stock performance of First Financial Northwest, Inc. (FFNW) remained stable. Based on the data provided by CNN Money, FFNW’s total revenue for the past year was $62.49 million, showing an increase of 8.77% compared to the previous year. Similarly, FFNW’s net income for the past year was $13.20 million, reflecting an 8.24% increase compared to the previous year. The earnings per share (EPS) for FFNW stood at $1.45 for the past year, indicating a 12.44% increase compared to the previous year. Overall, FFNW’s stock performance on January 12, 2024, can be characterized as stable and consistent. The company has shown growth in total revenue, net income, and EPS over the past year, indicating a positive trend. Investors and analysts may view FFNW as a reliable and consistent investment option based on its steady financial performance. However, further analysis and evaluation of FFNW’s financial statements and market conditions are essential to make informed investment decisions.

Tags: FFNW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Delta Air Lines Adapts Pilot Hiring Strategy for Changing Aviation Landscape

Food Retailers Trading online

Piper Sandler Analyst Maintains Neutral Stance on Hormel Foods with Revised Price Target

Technology Data analytics stock Trading (1)

Analyst Ratings and Price Targets for Five9 An Overview of Sentiments and Targets

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com